Insider Trading Stories

Acquisition by Lawrence Kochard of 580 shares of Janus Capital subject to Rule 16b 3

 58 minutes ago at MacroaxisInsider 
Filed By Lawrence Kochard, Janus Capital Group
Filed transaction by Janus Capital Group Inc director. Grant, award or other acquisition pursuant to Rule 16b-3. Janus insider trading alert for grant of common stock - rsu by Lawrence Kochard, the corporate stakeholder, on 31st of October 2020. This event was filed by Janus Capital Group Inc with SEC on 2017-05-22. Statement of changes in beneficial ownership - SEC Form 4 [more]
Millennials Best null Janus capital
Stoke Therapeutics
  just now at Macroaxis
Filed for Liau Gene
Filed transaction by Stoke Therapeutics Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3. Stoke insider trading alert for exercise of employee stock option (right to buy) by Liau Gene, EVP Research & Preclinical Dev, on 20th of October 2020. This event was filed by Stoke Therapeutics Inc with SEC on 2020-10-20. Statement of changes in beneficial ownership - SEC Form 4  
Stoke Therapeutics
  just now at Macroaxis
Filed for Liau Gene
Filed transaction by Stoke Therapeutics Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3. Stoke insider trading alert for exercise of employee stock option (right to buy) by Liau Gene, EVP Research & Preclinical Dev, on 13th of October 2020. This event was filed by Stoke Therapeutics Inc with SEC on 2020-10-13. Statement of changes in beneficial ownership - SEC Form 4  
TWO HANDS CORP
  30 minutes ago at Macroaxis
Filed for Gryfe Steven
Filed transaction by Two Hands Corp officer. Grant, award or other acquisition pursuant to Rule 16b-3(d). TWO HANDS insider trading alert for grant of common stock by Gryfe Steven, Chief Financial Officer, on 23rd of October 2020. This event was filed by Two Hands Corp with SEC on 2020-10-23. Statement of changes in beneficial ownership - SEC Form 4  
Atlas Financial Hlds
  36 minutes ago at Macroaxis
Filed for Giles Bruce Wayne
Filed transaction by Atlas Financial Holdings executive. Grant, award or other acquisition pursuant to Rule 16b-3(d). Atlas insider trading alert for grant of common shares by Giles Bruce Wayne, the corporate stakeholder, on 30th of October 2020. This event was filed by Atlas Financial Holdings with SEC on 2020-10-30. Statement of changes in beneficial ownership - SEC Form 4  
Asta Funding
  45 minutes ago at Macroaxis
Filed for David Slackman
Filed transaction by Asta Funding Inc director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e). Asta Funding insider trading alert for disposition of stock option (right to buy) by David Slackman, the corporate stakeholder, on 15th of October 2020. This event was filed by Asta Funding Inc with SEC on 2020-10-15. Statement of changes in beneficial ownership - SEC Form 4  
ConnectOne Bancorp
  46 minutes ago at Macroaxis
Filed for Frank Sorrentino
Filed transaction by Connectone Bancorp Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3. ConnectOne insider trading alert for exercise of stock option by Frank Sorrentino, Chairman President & CEO, on 30th of October 2020. This event was filed by Connectone Bancorp Inc with SEC on 2020-10-30. Statement of changes in beneficial ownership - SEC Form 4  
Aimmune Therapeutics
  49 minutes ago at Macroaxis
Filed for Andrew Oxtoby
Filed transaction by Aimmune Therapeutics Inc officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e). Aimmune insider trading alert for disposition of stock option (right to buy) by Andrew Oxtoby, Chief Commercial Officer, on 14th of October 2020. This event was filed by Aimmune Therapeutics Inc with SEC on 2020-10-14. Statement of changes in beneficial ownership - SEC Form 4  
Aimmune Therapeutics
  49 minutes ago at Macroaxis
Filed for Societe Des Produits Nestle Sa
Filed transaction by Aimmune Therapeutics Inc executive. Unconventional Insider trading. Aimmune insider trading alert for general transaction of series a preferred stock by Societe Des Produits Nestle Sa, the corporate stakeholder, on 15th of October 2020. This event was filed by Aimmune Therapeutics Inc with SEC on 2020-10-15. Statement of changes in beneficial ownership - SEC Form 4  
FinTech Acquisition
  51 minutes ago at Macroaxis
Filed for Fintech Masala Advisors Llc
Filed transaction by Fintech Acquisition Corp executive. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3. FinTech insider trading alert for exercise of class b common stock by Fintech Masala Advisors Llc, the corporate stakeholder, on 20th of October 2020. This event was filed by Fintech Acquisition Corp with SEC on 2020-10-20. Statement of changes in beneficial ownership - SEC Form 4